We are live on ! Find out more
CDAK

Codiak BioSciences, Inc. Common Stock
CDAK

Delisted

CDAK was delisted on the 4th of April, 2023.

Back to rankings

47 hedge funds and large institutions have $310M invested in Codiak BioSciences, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$37.2M
2
FP
Flagship Pioneering
Massachusetts
+$34.5M
3
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$10.8M
4
BC
Boxer Capital
California
+$7.97M
5
DM
Deerfield Management
New York
+$5.95M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$84.7M +$37.2M +2,815,151 New
FP
2
Flagship Pioneering
Massachusetts
$84.2M +$34.5M +2,607,303 New
Ensign Peak Advisors
3
Ensign Peak Advisors
Utah
$26.5M +$10.8M +819,827 New
BC
4
Boxer Capital
California
$19.5M +$7.97M +602,650 New
DM
5
Deerfield Management
New York
$14.5M +$5.95M +450,000 New
BlackRock
6
BlackRock
New York
$13.9M +$5.7M +431,002 New
Franklin Resources
7
Franklin Resources
California
$12M +$4.9M +370,418 New
HA
8
HHLR Advisors
Cayman Islands
$11.8M +$4.85M +366,721 New
APF
9
Alaska Permanent Fund
Alaska
$10.8M +$4.41M +333,333 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$6.06M +$2.48M +187,712 New
EC
11
EcoR1 Capital
California
$3.72M +$1.52M +115,195 New
Victory Capital Management
12
Victory Capital Management
Texas
$3.05M +$1.25M +94,303 New
CC
13
Casdin Capital
New York
$2.48M +$1.01M +76,688 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.37M +$972K +73,457 New
State Street
15
State Street
Massachusetts
$2.17M +$887K +67,054 New
Northern Trust
16
Northern Trust
Illinois
$2.07M +$847K +64,028 New
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$1.93M +$792K +59,841 New
Morgan Stanley
18
Morgan Stanley
New York
$986K +$403K +30,502 New
Jacobs Levy Equity Management
19
Jacobs Levy Equity Management
New Jersey
$715K +$293K +22,129 New
MCM
20
Moore Capital Management
New York
$676K +$277K +20,942 New
FIG
21
Freed Investment Group
Massachusetts
$657K +$269K +20,328 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$572K +$235K +17,732 New
JP Morgan Chase
23
JP Morgan Chase
New York
$489K +$201K +15,158 New
CCM
24
CAAS Capital Management
New York
$485K +$198K +15,000 New
ZP
25
Zimmer Partners
New York
$418K +$171K +12,933 New
1
2

CDAK Hedge Fund Activity: Q4 2020 in Review

47 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Codiak BioSciences, Inc. Common Stock (CDAK) for Q4 2020, worth a combined $310M.

Buyers outnumbered sellers: 47 funds opened new CDAK positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $37.2M.

  • 47 institutional investors held Codiak BioSciences, Inc. Common Stock (CDAK) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $310M of Codiak BioSciences, Inc. Common Stock stock for Q4 2020.
  • 47 funds opened new Codiak BioSciences, Inc. Common Stock positions in Q4 2020 and 0 closed out, a net change of +47 holders.
  • The largest Codiak BioSciences, Inc. Common Stock buyer in Q4 2020 was Fidelity Investments, an estimated $37.2M added.

Based on aggregated 13F filings for Q4 2020.